Research Article
Fabrication, Characterization, and In Vivo Evaluation of Famotidine Loaded Solid Lipid Nanoparticles for Boosting Oral Bioavailability
Table 4
value of different kinetic models for FTD-SLNs formulation.
| Formulations | Zero order () | First order () | Higuchi model () | Korsmeyer-Peppas model | Release exponent () | () |
| FFSe-1 | 0.958 | 0.866 | 0.966 | 0.82067309 | 0.978 | FFSe-2 | 0.973 | 0.960 | 0.955 | 0.89488353 | 0.965 | FFSe-3 | 0.981 | 0.976 | 0.956 | 0.89479258 | 0.962 | FFSe-4 | 0.991 | 0.985 | 0.950 | 0.93489612 | 0.947 | FFSe-5 | 0.993 | 0.989 | 0.949 | 0.94189608 | 0.940 |
|
|